Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 44.7% | -1.8% | 298.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 20.7% | 25.5% | 18.9% | 30.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -46.1% | -51.4% | -36.9% | -0.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.1% | -53.3% | -37.7% | -0.2% |
| EPS Diluted | -0.52 | -0.6 | -0.29 | -0.001 |
| % Growth | 13.3% | -106.9% | -57,900% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |